Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03BGG
|
|||
Former ID |
DIB015691
|
|||
Drug Name |
ST-1141
|
|||
Synonyms |
Ghrelin agonist (oral, opioid-induced bowel dysfunction), Helsinn
Click to Show/Hide
|
|||
Indication | Functional bowel disorder [ICD-11: DD91; ICD-10: K00-K93] | Phase 1 | [1] | |
Company |
Sapphire Therapeutics Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Growth hormone secretagogue receptor 1 (GHSR) | Target Info | Agonist | [2] |
KEGG Pathway | cAMP signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | Leptin Signaling Pathway | |||
Reactome | Peptide ligand-binding receptors | |||
G alpha (q) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025998) | |||
REF 2 | The Prokinetic Face of Ghrelin. International Journal of Peptides Volume 2010 (2010), Article ID 493614, Page(11). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.